Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals

Neuroscience

Volumn 170, Issue 1, 2010, Pages 67-77

  Bruzzone, F ^a   Cervetto, C ^a   Mazzotta, M C ^a   Bianchini, P ^a   Ronzitti, E ^a   Leprince, J ^b   Diaspro, A ^a,c   Maura, G ^a,d   Vallarino, M ^a   Vaudry, H ^b   Marcoli, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITÉ DE ROUEN   (France)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d National Institute of Neuroscience   (Italy)

Author keywords

Cholinergic nerve terminals; Motoneurons; Synaptosomes; UT receptor

Indexed keywords

ACETYLCHOLINE; CALCIUM; UROTENSIN RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CERVICAL SPINAL CORD; CHOLINERGIC NERVE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; EVOKED RESPONSE; MALE; MOTONEURON; MOTOR CONTROL; MOTOR PERFORMANCE; MOUSE; NERVE ENDING; NERVE FIBER; NERVE STIMULATION; NEUROMODULATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIKARYON; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD VENTRAL HORN; SYNAPTOSOME;

ACETYLCHOLINE; ANIMALS; CERVICAL VERTEBRAE; MALE; MICE; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; PRESYNAPTIC TERMINALS; QUINOLINES; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD; UREA; UROTENSINS;

EID: 77955926562     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.070     Document Type: Article

References (73)

1. Alvarez F.J., Dewey D.E., McMillin P., Fyffe R.E.W. Distribution of cholinergic contacts on Renshaw cells in the rat spinal cord: a light microscopic study. J Physiol 1999, 515:787-797.
2. Alvarez F.J., Fyffe R.E.W. The continuing case for the Renshaw cell. J Physiol 2007, 584:31-45.
3. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., Louden C.S., Foley J.J., Sauermelch C.F., Coatney R.W., Ao Z., Disa J., Holmes S.D., Stadel J.M., Martin J.D., Liu W.S., Glover G.I., Wilson S., McNulty D.E., Ellis C.E., Elshourbagy N.A., Shabon U., Trill J.J., Hay D.W., Ohlstein E.H., Bergsma D.J., Douglas S.A. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999, 401:282-286.
4. Arvidsson U., Riedl M., Elde R., Meister B. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 1997, 378:454-467.
5. Barber R.P., Phelps P.E., Houser C.R., Crawford G.D., Salvaterra P.M., Vaughn J.E. The morphology and distribution of neurons containing choline acetyltransferase in the adult rat spinal cord: an immunocytochemical study. J Comp Neurol 1984, 229:329-346.
6. Behm D.J., Harrison S.M., Ao Z., Maniscalco K., Pickering S.J., Grau E.V., Woods T.N., Coatney R.W., Doe C.P., Willette R.N., Johns D.G., Douglas S.A. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knock out mice. Br J Pharmacol 2003, 139:464-472.
7. Bellier J.P., Kimura H. Acetylcholine synthesis by choline acetyltransferase of a peripheral type as demonstrated in adult rat dorsal root ganglion. J Neurochem 2007, 101:1607-1618.
8. Bodian D. An electron microscopic characterization of classes of synaptic vesicles by means of controlled aldehyde fixation. J Cell Biol 1970, 44:115-124.
9. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
10. Brailoiu E., Brailoiu G.C., Miyamoto M.D., Dun N.J. The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br J Pharmacol 2003, 138:1580-1588.
11. Chartrel N., Conlon J.M., Collin F., Braun B., Waugh D., Vallarino M., Lahrichi S.L., Rivier J.E., Vaudry H. Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J Comp Neurol 1996, 364:324-339.
12. Chartrel N., Leprince J., Dujardin C., Chatenet D., Tollemer H., Baroncini M., Balment R.J., Beauvillain J.C., Vaudry H. Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 2004, 91:110-118.
13. Chatenet D., Dubessy C., Leprince J., Boularan C., Carlier L., Ségalas-Milazzo I., Guilhaudis L., Oulyadi H., Davoust D., Scalbert E., Pfeiffer B., Renard P., Tonon M.C., Lihrmann I., Pacaud P., Vaudry H. Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 2004, 25:1819-1830.
14. Clark S.D., Nothacker H.P., Wang Z., Saito Y., Leslie F.M., Civelli O. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res 2001, 923:120-127.
15. Clozel M., Binkert C., Birker-Robaczewska M., Boukhadra C., Ding S.S., Fischli W., Hess P., Mathys B., Morrison K., Müller C., Müller C., Nayler O., Qiu C., Rey M., Scherz M.W., Velker J., Weller T., Xi J.F., Ziltener P. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 2004, 311:204-212.
16. Conradi S. Ultrastructure and distribution of neuronal and glial elements on the surface of the proximal part of a motoneuron dendrite, as analyzed by serial sections. Acta Physiol Scand Suppl 1969, 332:49-64.
17. Coulouarn Y., Fernex C., Je'gou S., Henderson C.E., Vaudry H., Lihrmann I. Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech Dev 2001, 101:187-190.
18. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 1999, 457:28-32.
19. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., Conlon M., Bern H., Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 1998, 95:15803-15808.
20. Cullheim S., Kellerth J.O., Conradi S. Evidence for direct synaptic interconnections between cat spinal alpha-motoneurons via the recurrent axon collaterals: a morphological study using intracellular injection of horseradish peroxidase. Brain Res 1977, 132:1-10.
21. Diaspro A. Confocal and two-photon microscopy 2002, Wiley-Liss Inc, New York, NY.
22. do Rego J.C., Leprince J., Scalbert E., Vaudry H., Costentin J. Behavioral actions of urotensin-II. Peptides 2008, 29:838-844.
23. Douglas S.A., Dhanak D., Johns D.G. From "gills to pills": urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci 2004, 25:76-85.
24. Douglas S.A., Naselsky D., Ao Z., Disa J., Herold C.L., Lynch F., Aiyar N.V. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br J Pharmacol 2004, 142:921-932.
25. Douglas S.A., Ohlstein E.H. Urotensin receptors. The IUPHAR compendium of receptor characterization and classification 2000, 365-372. IUPHAR Media, London. G. D (Ed.).
26. Douglas S.A., Ohlstein E.H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 2000, 10:229-237.
27. Dubessy C., Cartier D., Lectez B., Bucharles C., Chartrel N., Montero-Hadjadje M., Bizet P., Chatenet D., Tostivint H., Scalbert E., Leprince J., Vaudry H., Jégou S., Lihrmann I. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. J Neurochem 2008, 107:361-374.
28. Dun S.L., Brailoiu G.C., Yang J., Chang J.K., Dun N.J. Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 2001, 305:9-12.
29. Egginger J.G., Camus A., Calas A. Urotensin-II expression in the mouse spinal cord. J Chem Neuroanat 2006, 31:146-154.
30. Elshourbagy N.A., Douglas S.A., Shabon U., Harrison S., Duddy G., Sechler J.L., Ao Z., Maleeff B.E., Naselsky D., Disa J., Aiyar N.V. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 2002, 136:9-22.
31. Feniuk W., Jarvie E., Luo J., Humphrey P.P.A. Selective somatostatin sst2 receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 2000, 39:1443-1450.
32. Ferguson S.M., Savchenko V., Apparsundaram S., Zwick M., Wright J., Heilman C.J., Yi H., Levey A.I., Blakely R.D. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 2003, 23:9697-9709.
33. Filipeanu C.M., Brailoiu E., Le Dun S., Dun N.J. Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J Neurochem 2002, 83:879-884.
34. Gilmor M.L., Nash N.R., Roghani A., Edwards R.H., Yi H., Hersch S.M., Levey A.I. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 1996, 16:2179-2190.
35. Gualix J., Gomez-Villafuertes R., Diaz-Hernandez M., Miras-Portugal M.T. Presence of functional ATP and dinucleotide receptors in glutamatergic synaptic terminals from rat midbrain. J Neurochem 2003, 87:160-171.
36. Hellstrom J., Oliveira A.L.R., Meister B., Cullheim S. Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2. J Comp Neurol 2003, 460:476-486.
37. Horie S., Yasuda S., Tsurumaki Y., Someya A., Saito T., Okuma Y., Nomura Y., Hirabayashi T., Murayama T. Contraction of isolated guinea-pig ileum by urotensin II via activation of ganglionic cholinergic neurons and acetylcholine release. Neuropharmacology 2003, 45:1019-1027.
38. Huitron-Resendiz S., Kristensen M.P., Sanchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., Suzuki C., Nothacker H.P., Civelli O., Criado J.R., Henriksen S.J., Leonard C.S., de Lecea L. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 2005, 25:5465-5474.
39. Israel M., Whittaker V.P. The isolation of mossy fibre endings from the granular layer of the cerebellar cortex. Experientia 1965, 21:325-326.
40. Ito T., Hioki H., Nakamura K., Kaneko T., Iino S., Nojyo Y. Some γ-motoneurons contain γ-aminobutyric acid in the rat cervical spinal cord. Brain Res 2008, 1201:78-87.
41. Jegou S., Cartier D., Dubessy C., Gonzalez B.J., Chatenet D., Tostivint H., Scalbert E., Leprince J., Vaudry H., Lihrmann I. Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 2006, 495:21-36.
42. Jope R.S. Acetylcholine turnover and compartmentation in rat brain synaptosomes. J Neurochem 1981, 36:1712-1721.
43. Labarrere P., Chatenet D., Leprince J., Marionneau C., Loirand G., Tonon M.C., Dubessy C., Scalbert E., Pfeiffer B., Renard P., Calas B., Pacaud P., Vaudry H. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J Enzyme Inhib Med Chem 2003, 18:77-88.
44. Leprince J., Gandolfo P., Thoumas J.L., Patte C., Fauchère J.L., Vaudry H., Tonon M.C. Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. J Med Chem 1998, 41:4433-4438.
45. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams D.L., Davidoff M., Wang R., Austin C.P., McDonald T.P., Bai C., George S.R., Evans J.F., Caskey C.T. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 1999, 266:174-178.
46. Malagon M.M., Molina M., Gahete M.D., Duran-Prado M., Martinez-Fuentes A.J., Alcain F.J., Tonon M.C., Leprince J., Vaudry H., Castaño J.P., Vazquez-Martinez R. Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5. Peptides 2008, 29:711-720.
47. 2+ ions in their function and desensitization. Neurochem Int 1999, 34:319-328.
48. Marchi M., Paudice P., Caviglia A., Raiteri M. Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors?. Eur J Pharmacol 1983, 91:63-68.
49. Marcoli M., Cervetto C., Paluzzi P., Guarnieri S., Alloisio S., Thellung S., Nobile M., Maura G. P2X7 presynaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release. J Neurochem 2008, 105:2330-2342.
50. Matsumoto M., Xie W., Inoue M., Ueda H. Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain 2007, 3:41. 10.1186/1744-8069-3-41.
51. Maura G., Carbone R., Guido M., Pestarino M., Raiteri M. 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur J Pharmacol 1991, 202:185-190.
52. Mentis G.Z., Alvarez F.J., Bonnot A., Richards D.S., Gonzalez-Forero D., Zerda R., O'Donovan M.J. Noncholinergic excitatory actions of motoneurons in the neonatal mammalian spinal cord. Proc Natl Acad Sci U S A 2005, 102:7344-7349.
53. Miles G.B., Hartley R., Todd A.J., Brownstone R.M. Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion. Proc Natl Acad Sci U S A 2007, 104:2448-2453.
54. Nakamura Y., Iga K., Shibata T., Shudo M., Kataoka K. Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia 1993, 9:48-56.
55. Nishimaru H., Restrepo C.E., Ryge J., Yanagawa Y., Kiehn O. Mammalian motor neurons corelease glutamate and acetylcholine at central synapses. Proc Natl Acad Sci U S A 2005, 102:5245-5249.
56. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., Duckles S.P., Civelli O. Identification of the natural ligand of an orphan G-protein couplet receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1999, 1:383-385.
57. Obata H., Li X., Eisenach J.C. α2-Adrenoceptor activation by clonidine enhances stimulation-evoked acetylcholine release from spinal cord tissue after nerve ligation in rats. Anesthesiology 2005, 102:657-662.
58. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., Bern H.A. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A 1980, 77:5021-5024.
59. Pelletier G., Lihrmann I., Dubessy C., Luu-The V., Vaudry H., Labrie F. Androgenic down-regulation of urotensin II precursor, urotensin II related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 2005, 132:689-696.
60. Pelletier G., Lihrmann I., Vaudry H. Role of androgens on the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 2002, 115:525-532.
61. 3H]ACh synthesis and release in rat hippocampal synaptosomes. Brain Res 1992, 586:148-151.
62. Poli A., Notari S., Virgili M., Fabbri E., Lucchi R. Neurochemical changes in cerebellum of goldfish exposed to various temperatures. Neurochem Res 1997, 22:141-149.
63. Prosser H.C., Forster M.E., Richards A.M., Pemberton C.J. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury. Peptides 2008, 29:770-777.
64. Qi J.S., Minor L.K., Smith C., Hu B., Yang J., Andrade-Gordon P., Damiano B. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 2005, 26:683-690.
65. Raiteri M., Angelini F., Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 1974, 25:411-414.
66. Raiteri L., Stigliani S., Usai C., Diaspro A., Paluzzi S., Milanese M., Raiteri M., Bonanno G. Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord. Neurochem Int 2008, 52:103-112.
67. Roghani A., Shirzadi A., Butcher L.L., Edwards R.H. Distribution of the vesicular transporter for acetylcholine in the rat central nervous system. Neuroscience 1998, 82:1195-1212.
68. Rossowski W.J., Cheng B.L., Taylor J.E., Datta R., Coy D.H. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 2002, 438:159-170.
69. Taupin P., Zini S., Cesselin F., Ben-Ari Y., Roisin M.P. Subcellular fractionation on Percoll gradient of mossy fiber synaptosomes: morphological and biochemical characterization in control and degranulated rat hippocampus. J Neurochem 1994, 62:1586-1595.
70. VanderHorst V.G.J.M., Ulfhake B. The organization of the brainstem and spinal cord of the mouse: relationships between monoaminergic, cholinergic, and spinal projection systems. J Chem Neuroanat 2006, 31:2-36.
71. Wilkinson G.F., Feniuk W., Humphrey P.P.A. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism. Br J Pharmacol 1997, 121:91-96.
72. Wilson J.M., Rempel J., Brownstone R.M. Postnatal development of cholinergic synapses on mouse spinal motoneurons. J Comp Neurol 2004, 474:13-23.
73. Zagoraiou L., Akay T., Martin J.F., Brownstone R.M., Jessell T.M., Miles G.B. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron 2009, 64:645-662.